| Preventing problematic internet use during the COVID-19 pandemic: Consensus guidance O Király, MN Potenza, DJ Stein, DL King, DC Hodgins, JB Saunders, ... Comprehensive psychiatry 100, 152180, 2020 | 940 | 2020 |
| Mephedrone, new kid for the chop? AR Winstock, LR Mitcheson, P Deluca, Z Davey, O Corazza, F Schifano Addiction 106 (1), 154-161, 2011 | 428 | 2011 |
| Mephedrone (4-methylmethcathinone;‘meow meow’): chemical, pharmacological and clinical issues F Schifano, A Albanese, S Fergus, JL Stair, P Deluca, O Corazza, Z Davey, ... Psychopharmacology 214, 593-602, 2011 | 359 | 2011 |
| Manifesto for a European research network into problematic usage of the internet NA Fineberg, Z Demetrovics, DJ Stein, K Ioannidis, MN Potenza, ... European Neuropsychopharmacology 28 (11), 1232-1246, 2018 | 317 | 2018 |
| Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project P Deluca, Z Davey, O Corazza, L Di Furia, M Farre, LH Flesland, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 39 (2), 221-226, 2012 | 250 | 2012 |
| Following “the Roots” of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a … E Cinosi, G Martinotti, P Simonato, D Singh, Z Demetrovics, ... BioMed research international 2015 (1), 968786, 2015 | 236 | 2015 |
| Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data F Schifano, S D’Offizi, M Piccione, O Corazza, P Deluca, Z Davey, ... Psychotherapy and psychosomatics 80 (2), 118-122, 2011 | 226 | 2011 |
| Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine O Corazza, F Schifano, P Simonato, S Fergus, S Assi, J Stair, J Corkery, ... Human Psychopharmacology: Clinical and Experimental 27 (2), 145-149, 2012 | 176 | 2012 |
| e-Psychonauts: conducting research in online drug forum communities Z Davey, F Schifano, O Corazza, P Deluca, ... Journal of Mental Health 21 (4), 386-394, 2012 | 173 | 2012 |
| Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project O Corazza, S Assi, P Simonato, J Corkery, FS Bersani, Z Demetrovics, ... Human Psychopharmacology: Clinical and Experimental 28 (4), 317-323, 2013 | 163 | 2013 |
| From “Special K” to “Special M”: the evolution of the recreational use of ketamine and methoxetamine O Corazza, S Assi, F Schifano CNS neuroscience & therapeutics 19 (6), 454-460, 2013 | 147 | 2013 |
| The emergence of Exercise Addiction, Body Dysmorphic Disorder, and other image-related psychopathological correlates in fitness settings: A cross sectional study O Corazza, P Simonato, Z Demetrovics, R Mooney, K Van De Ven, ... PloS one 14 (4), e0213060, 2019 | 128 | 2019 |
| 25C‐NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug FS Bersani, O Corazza, G Albano, G Valeriani, R Santacroce, ... BioMed research international 2014 (1), 734749, 2014 | 121 | 2014 |
| Designer drugs on the internet: a phenomenon out-of-control? The emergence of hallucinogenic drug Bromo-Dragonfly O Corazza, F Schifano, M Farre, P Deluca, Z Davey, C Drummond, ... Current clinical pharmacology 6 (2), 125-129, 2011 | 109 | 2011 |
| Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1, 4-butanediol (1, 4-BD; BDO): a literature review with a focus on UK fatalities related to non-medical use JM Corkery, B Loi, H Claridge, C Goodair, O Corazza, S Elliott, F Schifano Neuroscience & Biobehavioral Reviews 53, 52-78, 2015 | 108 | 2015 |
| Psychoactive drug or mystical incense? Overview of the online available information on Spice products F Schifano, O Corazza, P Deluca, Z Davey, L Di Furia, M Farre', ... International Journal of Culture and Mental Health 2 (2), 137-144, 2009 | 104 | 2009 |
| Problematic use of the internet during the COVID-19 pandemic: Good practices and mental health recommendations B Gjoneska, MN Potenza, J Jones, O Corazza, N Hall, CMD Sales, ... Comprehensive psychiatry 112, 152279, 2022 | 103 | 2022 |
| “Spice,”“kryptonite,”“black mamba”: an overview of brand names and marketing strategies of novel psychoactive substances on the web O Corazza, G Valeriani, FS Bersani, J Corkery, G Martinotti, G Bersani, ... Journal of Psychoactive Drugs 46 (4), 287-294, 2014 | 101 | 2014 |
| Sexual Enhancement Products for Sale Online: Raising Awareness of the Psychoactive Effects of Yohimbine, Maca, Horny Goat Weed, and Ginkgo biloba O Corazza, G Martinotti, R Santacroce, E Chillemi, M Di Giannantonio, ... BioMed Research International 2014 (1), 841798, 2014 | 98 | 2014 |
| ‘Legal highs’ an inappropriate term for ‘Novel Psychoactive Drugs’ in drug prevention and scientific debate O Corazza, Z Demetrovics, W van den Brink, F Schifano International Journal of Drug Policy 24 (1), 82-83, 2013 | 97 | 2013 |
Zsolt DemetrovicsCentre of Excellence in Responsible Gaming, University of Gibraltar, Gibraltar, GibraltarDirección de correo verificada de t-online.hu
